Alimemazine or trimeprazine

This classification denotes a sedative and hypnotic with the molecular formula C18H22N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 76H78MJJ52, chemically known as 10h-phenothiazine-10-propanamine, n,n,beta-trimethyl- but generally known as alimemazine, which bears US NIH Compound Identifier 5574. Alimemazine most often comes in base, s-dioxide, and tartrate forms. European Medicines Agency schedules Alimemazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05328MIG. The term ALIMEMAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules alimemazine in its Anatomical Therapeutic Chemical (ATC) Classification. ALIMEMAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Alimemazine or trimeprazine bears US NLM identifiers UMLS ID C0041031 and NCI Concept Code C72677. SMILES: CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C.